Elbow Heterotopic Ossifications Associated With Radial Head Prosthesis
Sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
About this trial
Last updated 2 years ago
Study ID
IIBSP-RAD-2022-52
Status
Recruiting
Type
Observational
Placebo
No
Accepting
18 to 85 Years
All
Trial Timing
Ended a year ago
What is this trial about?
Elbow heterotopic ossification (EHO) is described as the formation of ectopic bone in tissues
not supposed to around elbow. The EHO physiopathology, yet not clarified, has been suggested
to be a multifactorial process in which immune system, inflammatory response, CNS and tissue
expressed proteins after severe trauma boost hyperactive metabolically bone with no
periosteal layer. Consistent with that, EHO has been widely related to elbow trauma,
including bone, ligament, muscle or joint; iatrogenic trauma, including epicondylectomy or
elbow arthroplasty; neural injuries or burns. Clinical manifestations of EHO has been
reported as limited range of motion (ROM), muscle, nerve or joint pain, stiffness and
ankylosis all of them leading to upper extremity disfucntion. Prevalence of EHO can range
from 3%-45% depending on degree of elbow injury. To our knowledge, prevalence of EHO among
radial head fractures had not been assessed previously.
What are the participation requirements?
Inclusion Criteria
- Adults between 18-85 years-old
- Comminuted radial head fractures treated with radial head arthroplasty
Exclusion Criteria
- Younger than 18 years; Older than 85 years
- History of previous elbow injuries or operations.
- Pathologic fractures
- Infections
Locations
Location
Status
Recruiting
Recruiting